Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Price:
789.945
USD
-0.76%
Market Closed
Market Cap:
$82.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
C
|
CSL Ltd
XMUN:CSJ
|
AU |
|
F
|
Fortuna Mining Corp
NYSE:FSM
|
CA |
|
V
|
Vulcan Materials Co
SWB:VMC
|
US |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
|
G
|
Gold Fields Ltd
XMUN:EDGA
|
ZA |
|
SPAR Group Ltd
OTC:SGPPY
|
ZA |
|
M
|
Moderna Inc
F:0QF
|
US |
|
Recruit Holdings Co Ltd
F:1RHA
|
JP |
|
A
|
Aon PLC
F:4VK
|
IE |
|
C
|
Continental AG
XMUN:CON
|
DE |
|
Henry Schein Inc
NASDAQ:HSIC
|
US |
|
C
|
Chipotle Mexican Grill Inc
F:C9F
|
US |
|
E
|
Eni SpA
XMUN:ENI
|
IT |
|
D
|
Deutsche Bank AG
F:DBK
|
DE |
|
Orthofix Medical Inc
F:OM2
|
US |
|
U
|
United Parcel Service Inc
DUS:UPAB
|
US |
|
MultiChoice Group Ltd
F:30R
|
ZA |
|
A
|
Agnico Eagle Mines Ltd
F:AE9
|
CA |
|
R
|
Royal Bank of Canada
F:RYC
|
CA |
|
V
|
Vimian Group AB
STO:VIMIAN
|
SE |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
|
A
|
AT&T Inc
DUS:SOBA
|
US |
|
B
|
Brown & Brown Inc
DUS:BTW
|
US |
Wall St Price Targets
REGN Price Forecast
Based on 33 analysts
Based on 33 analysts
+10% Upside
from
$789.945
today
Regeneron Pharmaceuticals Inc (REGN)’s 12-month stock price forecast through September 2027 has a consensus target of $867, implying 10% upside. The forecast is based on price targets from 33 Wall Street analysts.
REGN Analyst Rating
Based on 25 analysts
Based on 25 analysts
Analysts rate REGN Buy, with 19 of 25 recommending Buy or Strong buy.
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is REGN's stock price target?
Price Target
867
USD
867
USD
According to Wall Street analysts, the average 1-year price target for REGN is 867 USD with a low forecast of 666.6 USD and a high forecast of 1 081.5 USD.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 8 years is 11%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 8%.